How Premature Can a Baby Be Born and Survive?

The youngest babies to survive birth today are born at around 22 weeks of gestation, roughly the midpoint of a typical pregnancy. At that age, about one in four survives to leave the hospital, but the odds improve sharply with each passing week: roughly half of babies born at 23 weeks survive, about seven in ten at 24 weeks, and more than eight in ten at 25 weeks. Those numbers, drawn from recent U.S. neonatal intensive care data, represent a dramatic shift from just a few decades ago, when the recognized limit of viability was 28 weeks. The answer to how early a baby can survive, though, depends on more than gestational age alone.

Survival Week by Week

Each additional week in the womb makes a large difference. A 2024 study of infants born between 2020 and 2022 in U.S. neonatal intensive care units found survival to hospital discharge of 24.9% at 22 weeks, 52.8% at 23 weeks, 71.1% at 24 weeks, and 82.1% at 25 weeks.¹ Those figures include all births at each gestational age, including some who died in the delivery room before receiving active treatment. Among infants who did receive postnatal life support, the 22-week survival rate was higher, about 35%, though survival without severe complications was only around 6%.

Survival alone does not capture the full picture. A Swedish study that followed extremely preterm infants into adulthood estimated the probability of disability-free survival to age 25 at roughly 4% for those born at 22 weeks, 20% at 23 weeks, 42% at 24 weeks, and 53% at 25 weeks.² By 28 weeks, the figure rose to about 78%, and full-term babies reached 97%. These numbers underscore how steeply the risks drop once the pregnancy extends past the earliest periviable window.

A meta-analysis covering studies from multiple decades found that the average chance of survival without impairment for babies born at 22 to 24 weeks rose from about 1% to 9% as neonatal care improved, while for those born at 25 to 27 weeks the rate climbed from roughly 41% to 64%.³ Progress is real, but the earliest weeks remain a zone where most survivors face lasting health challenges.

What Makes 22 to 24 Weeks So Precarious

The organs a baby needs to breathe, regulate temperature, and protect itself from infection are still in early construction at 22 weeks. The lungs are the most critical bottleneck. Surfactant, a mixture of molecules that keeps the tiny air sacs in the lungs from collapsing each time the baby exhales, only begins to appear in detectable amounts around 24 weeks of gestation.⁴ Without surfactant, premature infants develop respiratory distress syndrome, essentially gasping against lungs that refuse to stay inflated. Modern medicine can supply synthetic surfactant and mechanical ventilation, but at 22 or 23 weeks the lung tissue itself is so immature that even these interventions face steep biological limits.

The brain poses a separate set of risks. At these early gestational ages, a fragile network of capillaries called the germinal matrix lines the developing brain. These vessels are prone to bleeding, and hemorrhage can extend into the fluid-filled ventricles of the brain, potentially causing lasting neurological damage.⁵ The risk is highest in the most premature infants and is one of the main reasons that survival at 22 or 23 weeks often comes with serious complications.

Skin, too, plays a role that might not be obvious. A very premature baby’s skin has few protective layers and lacks the structural proteins that prevent water and heat from escaping. These infants lose water through the skin at high rates and struggle to maintain their body temperature, adding stress to systems that are already under enormous pressure.⁶ The skin barrier does mature quickly after birth, but the first weeks are a vulnerable window in which infection risk is also elevated because of the skin’s heightened permeability.⁷

Medical Interventions That Have Pushed the Limit Down

Two advances, more than any others, have shifted the boundary of viability over the past several decades. The first is antenatal corticosteroids: steroid injections given to the mother before delivery. These drugs accelerate lung maturation in the fetus, boosting surfactant production and reducing the severity of respiratory distress after birth. Antenatal corticosteroids are considered one of the most important interventions in obstetrics for improving preterm outcomes and have been proven effective for pregnancies at risk of preterm birth, though questions remain about their benefit at the very earliest gestational ages and in certain populations such as multiple pregnancies.⁸ Surfactant deficiency that contributes to respiratory distress syndrome can be significantly mitigated by this prenatal treatment.⁹

The second advance is postnatal surfactant replacement therapy. Giving synthetic surfactant directly into an infant’s lungs shortly after birth can dramatically improve breathing. A trial comparing early versus delayed surfactant administration in extremely premature infants found that early treatment roughly halved the combined rate of oxygen dependence or death, and also reduced the incidence of brain hemorrhage.¹⁰ Together, antenatal steroids and postnatal surfactant form the backbone of modern periviable care and explain much of the improvement in survival rates over recent decades.

Girls Survive at Higher Rates Than Boys

Sex is one of the strongest biological predictors of outcome after extremely preterm birth, and the advantage belongs to girls. A 16-year single-center study of extremely low birth weight infants found that females survived at a rate of about 79% compared with about 69% for males. Among the smallest babies, those weighing under 750 grams, the gap was even wider: 62% for girls versus 44% for boys.¹¹

The disadvantage extends beyond survival. Research on very preterm infants has found that boys have higher rates of death or oxygen dependence, longer hospital stays, more frequent brain abnormalities on ultrasound, and greater rates of disability and cognitive delay at follow-up. These differences persisted even after adjusting for birth weight and gestational age, pointing to a genuine biological vulnerability in males rather than simply a size difference.¹² A large Australian population study confirmed the pattern: male infants had roughly 40% higher odds of severe neonatal morbidity and higher odds of perinatal mortality overall.¹³ The reasons are not fully understood, but the evidence is consistent enough that neonatologists factor sex into their counseling with parents.

Where You Deliver Changes the Odds

The hospital where a very premature baby is born can matter as much as a full week of gestational age. Infants delivered at hospitals with high-level neonatal units have measurably lower mortality. A study across three U.S. states found significantly fewer in-hospital deaths when premature infants were delivered at centers with advanced NICUs compared with lower-level hospitals.¹⁴ An English study reinforced this, finding that very preterm infants admitted to high-volume neonatal units at the hospital of birth had roughly 30% lower odds of in-hospital death, and for those born before 27 weeks the benefit was even larger, with about half the mortality risk.¹⁵

At a global level, the disparities are stark. A systematic review found that survival of extremely preterm infants in low- and middle-income countries was about 44%, compared with roughly 69% in high-income countries.¹⁶ The gap reflects differences in equipment, staffing, drug availability, and the infrastructure needed to keep a baby weighing less than a pound alive for months at a time. When clinicians talk about the “limit of viability,” they are describing what is possible in the best-resourced settings. In much of the world, the practical limit remains several weeks later.

Long-Term Health After Extreme Prematurity

Surviving the NICU is the beginning of a longer story. The most common lasting consequences of extreme prematurity cluster in three areas: the brain, the lungs, and the eyes. A large study of children born extremely preterm found that at age ten, about 25% had cognitive impairment, 11% had cerebral palsy, 7% had autism spectrum disorder, and 7% had epilepsy. Nearly a fifth had one of these diagnoses, while about 10% had two and 3% had three, with lower gestational age linked to a higher burden of overlapping conditions.¹⁷ A review of the literature placed the range for intellectual disability at 5% to 36%, cerebral palsy at 9% to 18%, blindness up to 9%, and deafness at 2% to 4%, with wide variation depending on gestational age and the era of care.¹⁸

The lungs often carry a lasting imprint. Many extremely premature infants develop bronchopulmonary dysplasia, a chronic lung condition tied to the mechanical ventilation and oxygen therapy they needed at birth. While lung function improves as children grow, follow-up studies find that asthma-like symptoms, exercise intolerance, and abnormal airway function persist into young adulthood for some.¹⁹ In the most severely affected individuals, airflow obstruction continues into adulthood and can be worsened by environmental factors like smoking.²⁰

It is worth noting that many survivors of extreme prematurity, especially those born closer to 25 or 26 weeks, grow into adults without major disability. The picture is not uniformly bleak; it is a gradient that tracks closely with gestational age and the specific complications encountered in the NICU.

The Uncertainty in Gestational Age Itself

One complication that rarely gets discussed outside medical circles is that gestational age is an estimate, not a measurement. Dating is usually based on early ultrasound, but the further along the pregnancy, the less precise the estimate becomes. At the periviable border, even small errors change the prognosis dramatically. A study of ultrasound fetal weight estimation in very preterm infants found that among those in the 23- to 25-week range, the average error was about 10%, and the estimate fell within 10% of actual birth weight only half the time. In roughly one in six cases, the error exceeded 20%.²¹ This means that a baby estimated at 22 weeks might actually be 23 weeks, or vice versa, and the difference could mean a doubling of survival odds. Parents and clinicians making decisions at the edge of viability are, to some degree, working with imprecise information.

How Decisions Get Made at the Edge

At 22 and 23 weeks, whether to attempt full resuscitation is not a straightforward medical call. Many centers now support parental discretion, meaning parents and physicians together weigh the likely outcomes before deciding on a course of action. Some institutions have moved toward standardized guidelines that offer resuscitation to all infants born at 22 weeks or later, replacing older practices that discouraged intervention before 23 weeks.²²

Research into how parents experience these decisions reveals a disconnect that clinicians are still learning to bridge. Neonatologists tend to focus on medical management and survival statistics, while parents are often still processing the shock of a pregnancy going wrong. Studies have found that parents need more than just numbers: they need emotional support and engagement from the medical team to feel that the decision is genuinely shared rather than simply handed to them.²³ Financial concerns also weigh heavily. When researchers asked parents and clinicians to rank what mattered most in treatment decisions about periviable birth, both groups ranked financial concerns at or near the top.²⁴ A NICU stay for an extremely premature baby can last four to five months and cost hundreds of thousands of dollars, and for families without strong insurance coverage, the financial aftermath can be devastating regardless of the medical outcome.

A Moving Target

In 1971, a leading neonatology textbook estimated the limit of viability at 28 weeks.²⁵ Half a century later, resuscitation attempts at 22 weeks are routine in many centers, and survival at that age, while far from assured, is no longer exceptional. The limit has moved by roughly six weeks in a single generation of medical practice, driven by surfactant therapy, antenatal steroids, improvements in ventilator technology, and a growing willingness to offer intensive care at earlier gestational ages.

Whether the limit can be pushed further is an open question. One avenue of research that has attracted wide attention is artificial womb technology. In 2017, researchers demonstrated a system that kept extremely premature fetal lambs alive and developing normally outside the uterus for up to four weeks. The lambs, at a developmental stage equivalent to an extremely premature human infant, maintained stable circulation, normal blood gases, and showed appropriate lung maturation and brain growth.²⁶ The system, called EXTEND, has generated both excitement and caution. It represents a fundamentally different approach, keeping the fetus in a fluid-filled environment that mimics the womb rather than forcing immature lungs to breathe air, but moving from lambs to human infants raises enormous technical, ethical, and regulatory challenges.²⁷ Human trials have not yet occurred, and it remains unclear whether this technology will reach clinical use in the near term or remain a research tool for years to come. Still, the fact that it exists at all suggests that the limit of viability is unlikely to stay where it is.